Parkinson’s Disease Parkinson’s disease (PD) is a neurodegenerative movement disorder. It is characterised by the loss of dopaminergic neurons in […]
Cellular lysosomal degradative activity is key for healthy cell maintenance. As such, it is unsurprising that changes in the level […]
Written by Charlotte Harrison, Science Writer. Early detection of Parkinson’s disease (PD) will mean that future therapies have a better […]
Researchers have identified a Parkinson’s disease-linked mutation that impacts the endocytic protein Endophilin A1, which is involved in autophagy. In […]
An experimental small molecule treatment for Parkinson’s disease can correct hallmarks of the condition in cells and animals. The study, […]
The Festival of Genomics and Biodata is just around the corner, and we’ve had the opportunity to sit down with […]
This feature is written using content from our upcoming Liquid Biopsy report, due to be released late January 2024. Liquid […]
Welcome back to Week in Brief, our digest of the latest news from the genomics world and beyond! We have […]
A special issue of the Journal of Neuromuscular Diseases has been dedicated to the ‘Treatabolome’ – a new online database […]
Another jam-packed week of interesting research and news from the genomics space – all summarised here for you! Top stories […]
